These data further indicate that the IFN-γ-induced MDK during OC treatment may counteract the anti-proliferation role of IFN-γ and thus gave rise to a speculation of whether MDK inhibition would help reinforce the anti-tumor effect of IFN-γ by reducing MDK-mediated cell proliferation. The gene discussed is IFNG; the disease is neoplasm.